Of mice and men: The best laid scheme?

Timothy D. Henry; Heidi J. Reich; Andreas M. Zeiher

doi:10.1016/j.jacc.2015.02.035

Of mice and men: The best laid scheme?

Timothy D. Henry, Heidi J. Reich, Andreas M. Zeiher

Medicine - Cardiology Division

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1435-1437
Number of pages	3
Journal	Journal of the American College of Cardiology
Volume	65
Issue number	14
DOIs	https://doi.org/10.1016/j.jacc.2015.02.035
State	Published - Apr 14 2015

Bibliographical note

Funding Information:
Dr. Henry is Principal Investigator with NIH Cardiovascular Cell Therapy Research Network (CCTRN); ALLSTAR Trial, Capricor Inc.; I×Cell DCM Trial, Aastrom; and ATHENA Trial, Cytori; and is on the Steering Committee with NIH CCTRN; ALLSTAR Trial, Capricor Inc.; I×Cell DCM Trial, Aastrom; Chart-2, Cardio3 Biosciences; and ATHENA Trial, Cytori. Dr. Zeiher is scientific advisor and co-founder of t2cure. Dr. Reich’s research effort is supported by the TSFRE Braunwald Fellowship.

Keywords

CD34
angiogenesis
left ventricular assist device
stem cell

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.jacc.2015.02.035

OpenUrl availability

Full text

Cite this

@article{da148f5838bd41298c4133feb142e993,

title = "Of mice and men: The best laid scheme?",

keywords = "CD34, angiogenesis, left ventricular assist device, stem cell",

author = "Henry, {Timothy D.} and Reich, {Heidi J.} and Zeiher, {Andreas M.}",

note = "Funding Information: Dr. Henry is Principal Investigator with NIH Cardiovascular Cell Therapy Research Network (CCTRN); ALLSTAR Trial, Capricor Inc.; I×Cell DCM Trial, Aastrom; and ATHENA Trial, Cytori; and is on the Steering Committee with NIH CCTRN; ALLSTAR Trial, Capricor Inc.; I×Cell DCM Trial, Aastrom; Chart-2, Cardio3 Biosciences; and ATHENA Trial, Cytori. Dr. Zeiher is scientific advisor and co-founder of t2cure. Dr. Reich{\textquoteright}s research effort is supported by the TSFRE Braunwald Fellowship. ",

year = "2015",

month = apr,

day = "14",

doi = "10.1016/j.jacc.2015.02.035",

language = "English (US)",

volume = "65",

pages = "1435--1437",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "14",

}

TY - JOUR

T1 - Of mice and men

T2 - The best laid scheme?

AU - Henry, Timothy D.

AU - Reich, Heidi J.

AU - Zeiher, Andreas M.

N1 - Funding Information: Dr. Henry is Principal Investigator with NIH Cardiovascular Cell Therapy Research Network (CCTRN); ALLSTAR Trial, Capricor Inc.; I×Cell DCM Trial, Aastrom; and ATHENA Trial, Cytori; and is on the Steering Committee with NIH CCTRN; ALLSTAR Trial, Capricor Inc.; I×Cell DCM Trial, Aastrom; Chart-2, Cardio3 Biosciences; and ATHENA Trial, Cytori. Dr. Zeiher is scientific advisor and co-founder of t2cure. Dr. Reich’s research effort is supported by the TSFRE Braunwald Fellowship.

PY - 2015/4/14

Y1 - 2015/4/14

KW - CD34

KW - angiogenesis

KW - left ventricular assist device

KW - stem cell

UR - http://www.scopus.com/inward/record.url?scp=84926357454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926357454&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2015.02.035

DO - 10.1016/j.jacc.2015.02.035

M3 - Editorial

C2 - 25857909

AN - SCOPUS:84926357454

SN - 0735-1097

VL - 65

SP - 1435

EP - 1437

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 14

ER -

Of mice and men: The best laid scheme?

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this